Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Key Points Walgreens is an iconic brand in the pharmacy space, but it has fallen on hard times.The retailer has agreed to be ...

Walgreens Boots Alliance is going private at $11.45/share plus up to $3 via a CVR, offering a potential $14.45 payout. See ...

Walgreens posted quarterly earnings that beat analyst expectations this morning, ... Walgreens beats Wall Street expectations ahead of sale to Sycamore Partners By Jon Asplund ...

The transaction, expected to close in Q3 or Q4, will take the company private after nearly 100 years as a public company.

By overwhelmingly approving the $10 billion sale to private-equity firm Sycamore Partners, investors set an official end date on Walgreens’ run as one of Chicago’s most iconic public companies ...

Walgreens Boots Alliance (NASDAQ:WBA) is set to announce second quarter earnings on Tuesday and investors will focus on details of the sale progress about the company’s $10 billion deal to go ...

Walgreens’ third-quarter performance comes ahead of its $10 billion sale to private equity firm Sycamore Partners, expected to close by the end of 2025. The looming transaction has created ...

Walgreens swings to a loss ahead of Sycamore acquisition Store closures and weak front-of-store sales led to a retail sales decline in Q3, but U.S. pharmacy and international sales were strong.

Transaction expected to close in the third or fourth quarter of calendar year 2025 DEERFIELD, Ill.--(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (WBA) (the “Company” or “WBA”) today ...

Retail Gazette takes a closer look at Boots' new private equity owner and what the deal means for the future of the health ...

This would represent the third attempted sale of Boots since 2022. WBA previously sought a £7bn sale but withdrew after ...